Group leader
| Göran Alderborn | Pharmaceutics |
| Per Andrén | Medical Mass Spectrometry |
| Anders Backlund | Pharmacognosy |
| Robert Fredriksson | Molecular Neuropharmacology |
| Göran Frenning | Pharmaceutics |
| Ulf Göransson | Pharmacognosy |
| Mathias Hallberg | Biological research on drug dependence |
| Björn Hellman | Drug Safety & Toxicology |
| Greta Hultqvist | Protein and peptide drugs |
| Erik Jansson | Medical Mass Spectrometry |
| Johan Lennartsson | Pharmaceutical Cell Biology & Biotechnology |
| Hans Lennernäs | Translational Drug Discovery and Development |
| Sara Mangsbo | Protein and peptide drugs |
| Maria Norlin | Pharmaceutical Cell Biology & Biotechnology |
| Ingrid Nylander | Neuropharmacology, addiction and behaviour |
| Ulrika Simonsson | Translational Drug Discovery and Development |
| Ola Spjuth | Pharmaceutical Bioinformatics |
| Ola Söderberg | Pharmaceutical Cell Biology & Biotechnology |
Last modified: 2021-02-22